151 related articles for article (PubMed ID: 34933141)
1. Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant Enterobacterales bacteraemia: a cohort study.
Barros A; Monroy H; Bergo P; Beck E; David L; Rigatto MH
J Glob Antimicrob Resist; 2022 Mar; 28():130-135. PubMed ID: 34933141
[TBL] [Abstract][Full Text] [Related]
2. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.
Poline J; Postaire M; Parize P; Pilmis B; Bille E; Zahar JR; Frange P; Cohen JF; Lortholary O; Toubiana J
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1039-1048. PubMed ID: 33389261
[TBL] [Abstract][Full Text] [Related]
3. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
Paniagua-García M; Bravo-Ferrer JM; Pérez-Galera S; Kostyanev T; de Kraker MEA; Feifel J; Palacios-Baena ZR; Schotsman J; Cantón R; Daikos GL; Carevic B; Dragovac G; Tan LK; Raka L; Hristea A; Viale P; Akova M; Cano Á; Reguera JM; Bartoloni A; Florescu SA; Benea S; Bukarica L; Asensio Á; Korten V; Grundmann H; Goossens H; Bonten MJ; Gutiérrez-Gutiérrez B; Rodríguez-Baño J;
Clin Microbiol Infect; 2024 Feb; 30(2):223-230. PubMed ID: 38267096
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Intervention by an Antimicrobial Stewardship Team for Patients with Bacteremia].
Odawara M; Yamashina T; Irie K; Yamashita K; Tsuruta M; Tsukada H; Tsuruyama M; Kaneuchi H; Hara R; Kodama M; Kubo N; Hiraki Y
Yakugaku Zasshi; 2020; 140(2):319-328. PubMed ID: 32009051
[TBL] [Abstract][Full Text] [Related]
5. Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
Vasikasin V; Panuvatvanich B; Rawson TM; Holmes AH; Nasomsong W
J Antimicrob Chemother; 2023 Jul; 78(7):1748-1756. PubMed ID: 37252945
[TBL] [Abstract][Full Text] [Related]
6. A Cohort Study of the Impact of Carbapenem-Resistant
Sabino S; Soares S; Ramos F; Moretti M; Zavascki AP; Rigatto MH
mSphere; 2019 Apr; 4(2):. PubMed ID: 30971443
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
8. Handshake stewardship reduces carbapenem prescription in a pediatric critical care setting.
Kit-Anan W; Boonsathorn S; Anantasit N; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
Pediatr Int; 2022 Jan; 64(1):e15227. PubMed ID: 35912458
[TBL] [Abstract][Full Text] [Related]
9. [Impact of the Antimicrobial Stewardship Team Intervention Focusing on Changes in Prescribing Trends and the Rate of Carbapenem-resistant P. aeruginosa].
Naito Y; Maeda M; Nagatomo Y; Ugajin K; Akima E; Tanaka M; Tokimatsu I; Sasaki T
Yakugaku Zasshi; 2022; 142(5):527-534. PubMed ID: 35491159
[TBL] [Abstract][Full Text] [Related]
10. Comparison of carbapenem-susceptible and carbapenem-resistant
Lutgring JD; Kent AG; Bowers JR; Jasso-Selles DE; Albrecht V; Stevens VA; Pfeiffer A; Barnes R; Engelthaler DM; Johnson JK; Gargis AS; Rasheed JK; Limbago BM; Elkins CA; Karlsson M; Halpin AL
Microb Genom; 2023 Nov; 9(11):. PubMed ID: 37987646
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of antimicrobial stewardship programmes based on rapid antibiotic susceptibility testing of haematological patients having high-risk factors for bacteraemia-related mortality: a post-hoc analysis of a randomised controlled trial.
Kim JH; Kim TS; Chang E; Kang CK; Choe PG; Kim NJ; Oh MD; Park WB; Kim I
Int J Antimicrob Agents; 2022 Jul; 60(1):106604. PubMed ID: 35588970
[TBL] [Abstract][Full Text] [Related]
12. Impact of the multidisciplinary antimicrobial stewardship team intervention focusing on carbapenem de-escalation: A single-centre and interrupted time series analysis.
Suzuki A; Maeda M; Yokoe T; Hashiguchi M; Togashi M; Ishino K
Int J Clin Pract; 2021 Mar; 75(3):e13693. PubMed ID: 32893441
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of intervention for carbapenems and anti-methicillin-resistant Staphylococcus aureus antibiotics by an antimicrobial stewardship team.
Kagami K; Ishiguro N; Yamada T; Niinuma Y; Iwasaki S; Taki K; Fukumoto T; Hayasaka K; Nishida M; Sugita J; Teshima T; Sugawara M; Takekuma Y
Am J Infect Control; 2021 Dec; 49(12):1493-1498. PubMed ID: 34416316
[TBL] [Abstract][Full Text] [Related]
14. The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria.
Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Fujimoto H; Nakaie K; Okada Y; Fujita A; Kawaguchi H; Shinoda Y; Nakamura Y; Kaneko Y; Yoshida H; Kakeya H
J Infect Chemother; 2019 Dec; 25(12):1001-1006. PubMed ID: 31255524
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program.
Faraone A; Poggi A; Cappugi C; Tofani L; Riccobono E; Giani T; Fortini A
Eur J Intern Med; 2020 Aug; 78():50-57. PubMed ID: 32303455
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes.
Seah VXF; Ong RYL; Lim ASY; Chong CY; Tan NWH; Thoon KC
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28717037
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial.
Kim JH; Kim I; Kang CK; Jun KI; Yoo SH; Chun JY; Jung J; Kim YJ; Kim DY; Jo HB; Kim DY; Koh Y; Shin DY; Hong J; Kim NJ; Yoon SS; Kim TS; Park WB; Oh MD
Clin Microbiol Infect; 2021 Jan; 27(1):69-75. PubMed ID: 32272171
[TBL] [Abstract][Full Text] [Related]
19. The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia.
Kuwabara G; Yukawa S; Yamada K; Imoto W; Yamairi K; Shibata W; Yoshii N; Watanabe T; Asai K; Niki M; Nakaie K; Okada Y; Fujita A; Kaneko Y; Kawaguchi T; Kakeya H
Anaerobe; 2020 Aug; 64():102214. PubMed ID: 32446953
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
Hassoun-Kheir N; Hussien K; Karram M; Saffuri M; Badaan S; Peleg S; Aboelhega W; Warman S; Alon T; Pollak D; Szwarcwort Cohen M; Paul M
Antimicrob Resist Infect Control; 2023 Nov; 12(1):129. PubMed ID: 37986092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
